Ishikawa Tetsuo

イシカワテツオ | Ishikawa Tetsuo

Affiliation and department：
Job title： Associate Professor

Research field (1)： Cognitive neuroscience

Research theme for competitive and other funds (2)：

2021 - 2025 『生体リズムに着目した発達障害の解析ー胎児期から幼児期までの縦断研究ー』
2020 - 2023 Visualization and prediction of health and disease states using landscape models

Papers (28)：

Akiko Hanai, Tetsuo Ishikawa, Shoichiro Kawauchi, Yuta Iida, Eiryo Kawakami. Generative artificial intelligence and non-pharmacological bias: an experimental study on cancer patient sexual health communications. BMJ Health & Care Informatics. 2024. 31. 1. e100924
Koichi Ashizaki*, Tetsuo Ishikawa*, Yuko Nomura. Residual facial erythema in atopic dermatitis patients treated with dupilumab stratified by machine learning. Journal of the European Academy of Dermatology and Venereology. 2024
Akiko Hanai, Tetsuo Ishikawa, Shoko Sugao, Makoto Fujii, Kei Hirai, Hiroko Watanabe, Masayo Matsuzaki, Goji Nakamoto, Toshihiro Takeda, Yasuji Kitabatake, et al. Explainable Machine Learning Classification to Identify Vulnerable Groups Among Parenting Mothers: Web-Based Cross-Sectional Questionnaire Study. JMIR Formative Research. 2024. 8. e47372
Kazuhiro Sakurada, Tetsuo Ishikawa. Synthesis of causal and surrogate models by non-equilibrium thermodynamics in biological systems. Scientific Reports. 2024. 14. 1
Yusuke Ito, Satoshi Inoue, Takahiro Nakashima, Haosong Zhang, Yang Li, Hitomi Kasuya, Tetsuya Matsukawa, Zhiwen Wu, Toshiaki Yoshikawa, Mirei Kataoka, et al. Epigenetic profiles guide improved CRISPR/Cas9-mediated gene knockout in human T cells. Nucleic Acids Research. 2023

ｍore...

MISC (9)：

小口真司, 小口真司, 石川哲朗, 石川哲朗, 華井明子, 華井明子, 加藤大吾, 板倉昭二, 奥野昌子, 渡部基信, et al. Comprehensive Analysis of Sleep Dynamics in Children via non-negative tensor factorization. 日本小児科学会雑誌. 2024. 128. 2
華井明子, 華井明子, 石川哲朗, 石川哲朗, 石川哲朗, 川内翔一朗, 飯田裕太, 川上英良, 川上英良. 情報提供ツールとしてのGenerative Artificial Intelligenceの有用性の検討. 日本サイコオンコロジー学会総会(Web). 2023. 36th
千田克幸, 千田克幸, 石川哲朗, 石川哲朗, 石川哲朗, 華井明子, 華井明子, 花之枝彩香, 柏木佑介, 佐藤潤弥, et al. Elucidation of synergistic risk factors for nephrotic syndrome based on time-series statistical evaluation of comorbidities. 日本薬学会年会要旨集(Web). 2023. 143rd
川上英良, 石川哲朗, 華井明子, 大矢めぐみ. 衛生学の発展に向けた先制医療の可能性を考える予防・先制医療に向けたデータ駆動型アプローチ. 日本衛生学雑誌. 2022. 77. Suppl. S139-S139
川上英良, 川上英良, 石川哲朗, 華井明子, 大矢めぐみ, 大矢めぐみ. 予防・先制医療に向けたデータ駆動型アプローチ. 日本衛生学雑誌(Web). 2022. 77. Supplement

ｍore...

Patents (3)：

Books (1)：

CARLS Series of Advanced Study of Logic and Sensibility Vol.4
Keio University Press 2011

Lectures and oral presentations (96)：

Machine Learning to Predict the Risk of Incident Diabetic macular edema Among Patients With Diabetes
(1st Asia & Pacific Bioinformatics Joint Conference (APBJC2024), Okinawa, Japan)
Time-series application of a multiple statistical test to uncover risk factors among comorbidity combinations for nephrotic syndrome using a large claims database
(1st Asia & Pacific Bioinformatics Joint Conference (APBJC2024), Okinawa, Japan)
可視化を通じた健康・疾患状態の多様性の理解
(データサイエンスと生命医科学研究のフロンティア 2024)
Evaluation of Sleep Deviations in Children with Developmental Disorders Using AI
(10th Congress of the European Academy of Paediatric Societies (EAPS 2024), Vienna)
Exploring how the brain-gut axis is affected by personality traits, eating habits, and meditation practices.
(Neuroscience 2024, Chicago, USA)

ｍore...

Education (3)：

Work history (16)：

2024/10 - 現在 Institute of Sciecne Tokyo
2024/10 - 現在大阪大学 D3センター招へい研究員
2023/05 - 現在 The University of Tokyo
2022/04 - 現在野村皮膚科医院客員研究員
2022/04 - 現在 Keio University School of Medicine Department of Extended Intelligence for Medicine, The Ishii-Ishibashi Laboratory Associate Professor

Show all

Awards (5)：

2024/06 - 日本皮膚科学会第123回総会優秀演題賞
2023/10 - 第36回日本サイコオンコロジー学会総会優秀演題賞
2023/02 - 日本皮膚科学会アトピー性皮膚炎臨床研究奨励賞学会発表賞
2020/06 - 日本皮膚科学会第119回総会優秀演題賞
2020/03 - RIKEN Ohbu Industry Partnerships Incentive Award "State visualization device, state visualization method and state visualization program"

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page